FH and familial hyperaldosteronism: The CPCS strategy can identify about one new FH individual for every 70 children screened and provides a flow of unrelated index cases from whom cascade testing can be sustained, yielding an estimated four new FH cases per family (three FH-positive relatives per affected child).